These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 30662584)
1. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Cui HX; Hu YN; Li JW; Yuan K Oxid Med Cell Longev; 2018; 2018():8930374. PubMed ID: 30662584 [TBL] [Abstract][Full Text] [Related]
2. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788 [TBL] [Abstract][Full Text] [Related]
3. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway. Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028 [TBL] [Abstract][Full Text] [Related]
4. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Yao Y; Chen H; Yan L; Wang W; Wang D Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246 [TBL] [Abstract][Full Text] [Related]
5. Mogroside Alleviates Diabetes Mellitus and Modulates Intestinal Microflora in Type 2 Diabetic Mice. Qin T; Li Y; Wu Y; Meng F; Lin G; Xia X Biol Pharm Bull; 2024; 47(5):1043-1053. PubMed ID: 38811190 [TBL] [Abstract][Full Text] [Related]
6. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Zhang W; Xu JH; Yu T; Chen QK Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226 [TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443 [TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability. Cui HX; Hu YN; Li JW; Yuan K; Guo Y Molecules; 2018 Dec; 24(1):. PubMed ID: 30597911 [TBL] [Abstract][Full Text] [Related]
9. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms. Ni WJ; Ding HH; Tang LQ Eur J Pharmacol; 2015 Aug; 760():103-12. PubMed ID: 25912800 [TBL] [Abstract][Full Text] [Related]
10. Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway. Liu D; Zhang Y; Liu Y; Hou L; Li S; Tian H; Zhao T Exp Clin Endocrinol Diabetes; 2018 Sep; 126(8):513-520. PubMed ID: 29365334 [TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate-activated protein kinase modulation by berberine attenuates mitochondrial deficits and redox imbalance in experimental diabetic neuropathy. Yerra VG; Kalvala AK; Sherkhane B; Areti A; Kumar A Neuropharmacology; 2018 Mar; 131():256-270. PubMed ID: 29273519 [TBL] [Abstract][Full Text] [Related]
12. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. Zhu L; Han J; Yuan R; Xue L; Pang W Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956 [TBL] [Abstract][Full Text] [Related]
13. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Liu L; Yu YL; Yang JS; Li Y; Liu YW; Liang Y; Liu XD; Xie L; Wang GJ Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):371-81. PubMed ID: 20229011 [TBL] [Abstract][Full Text] [Related]
14. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway. Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556 [TBL] [Abstract][Full Text] [Related]
15. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947 [TBL] [Abstract][Full Text] [Related]
16. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. Tang LQ; Wei W; Chen LM; Liu S J Ethnopharmacol; 2006 Nov; 108(1):109-15. PubMed ID: 16759828 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic activity of the Baker's yeast β-glucan in obese/type 2 diabetic mice and the underlying mechanism. Cao Y; Zou S; Xu H; Li M; Tong Z; Xu M; Xu X Mol Nutr Food Res; 2016 Dec; 60(12):2678-2690. PubMed ID: 27396408 [TBL] [Abstract][Full Text] [Related]
18. Antihyperglycemic effect of the traditional Chinese scutellaria-coptis herb couple and its main components in streptozotocin-induced diabetic rats. Liu SZ; Deng YX; Chen B; Zhang XJ; Shi QZ; Qiu XM J Ethnopharmacol; 2013 Jan; 145(2):490-8. PubMed ID: 23183087 [TBL] [Abstract][Full Text] [Related]
19. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038 [TBL] [Abstract][Full Text] [Related]
20. Berberine chloride ameliorates oxidative stress, inflammation and apoptosis in the pancreas of Streptozotocin induced diabetic rats. Chandirasegaran G; Elanchezhiyan C; Ghosh K; Sethupathy S Biomed Pharmacother; 2017 Nov; 95():175-185. PubMed ID: 28843149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]